• Merck KGaA on strategic M&A, including its up to €1 billion immuno-oncology collaboration with F-Star and licensing and collaboration arrangements, followed by the subsequent restructure of those arrangements. 
    • Cerberus Capital Management on the sale of Covis Pharma to Apollo Global Management. 
    • Compass Pathways in relation to various funding rounds for its groundbreaking work with psilocybin.
    • One of the world's largest family offices on private equity and venture direct and co-investments in the life sciences and technology sectors.
    • London Zoo in relation to various commercial aspects of its operations, including negotiations with the UK government.
    • Peprotech Inc., a leading manufacturer of cytokines and antibodies for scientific application, in relation to various European corporate matters.
    • The Craftory, the US$400 million challenger brand investment fund, in relation to its structuring and equity funding by three of the world’s largest family offices.
    • Lynwood Investments in relation to its sale of some of its interest in Waterstones Booksellers to Elliott Private Equity.
    • Sedgwick Claims Management (then a KKR portfolio company) in relation to its acquisition of Cunningham Lindsey in the insurance sector.
    • Judges Scientific plc in relation to various acquisitions in the life sciences and health care sector.
    • Advent International in relation to the disposal of Oxea, one of the largest global manufacturers of Oxo chemicals, to Oman Oil Company.
    • Parthenon Capital LLC in relation to its sale of Med-Tel UK Limited, a leading diagnostic group.
    • Intertek Group plc in relation to various corporate matters.
    • Mitsubishi Heavy Industries on its global joint venture in metals machinery technology (with Siemens AG).
    • Inchcape plc in relation to M&A.
    • Bank Otkritie in relation to its acquisition of Rocket Bank (backed by Runa Capital). 
    • BCG Digital Ventures, Deutsche Telekom Venture Fund and Berlin Hyp Venture Fund in relation to various venture investments.
    • A substantial family office as investor in a substantive venture investment in a UK ticketing and events hosting company.
    • Ares Capital and Lyceum Capital in relation to various equity co-investments.

    Includes matters handled at Dechert or prior to joining the firm.

    • Birmingham University, B.A., 2001
    • BPP Law School, PgDL, 2002
    • BPP Law School, LPC, 2003
    • England and Wales
    • Ireland
    • Markets Group - Private Equity Europe Forum 2019 —  London, (September 5, 2019)